NASDAQ: JSPR
Jasper Therapeutics Inc Stock Ownership - Who owns Jasper Therapeutics?

Insider buying vs selling

Have Jasper Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Svetlana LucasDirector2025-09-2220,000$2.43
$48.60kBuy
Ron MartellPresident and CEO2025-09-2241,000$2.43
$99.63kBuy
Judith Anne ShizuruDirector2025-09-2241,000$2.43
$99.63kBuy
Thomas G. WiggansDirector2025-09-2241,000$2.43
$99.63kBuy

1 of 1

JSPR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JSPR insiders and whales buy or sell their stock.

JSPR Shareholders

What type of owners hold Jasper Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Roche Holding Ltd32.78%9,174,212$12.29MInsider
Qiming Us Healthcare Fund II LP30.44%8,519,648$11.42MInsider
Barney A. Richmond23.10%6,464,048$8.66MInsider
Kurt Von Emster20.19%5,649,733$7.57MInsider
Abingworth LLP20.11%5,628,558$7.54MInsider
Velan Capital Investment Management LP9.54%2,668,395$3.58MInstitution
Kenneth F. Clifford8.22%2,300,000$3.08MInsider
Balaji Venkataraman8.22%2,300,000$3.08MInsider
Amplitude Healthcare Holdings LLC8.22%2,300,000$3.08MInsider
Howard I. Hoffen8.22%2,300,000$3.08MInsider

1 of 3

JSPR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JSPR28.27%71.73%Net Buying
INMB19.12%27.83%
ATNM14.92%85.08%Net Selling
CELU2.23%97.77%Net Selling
TAOX8.34%3.53%Net Selling

Jasper Therapeutics Stock Ownership FAQ

Who owns Jasper Therapeutics?

Jasper Therapeutics (NASDAQ: JSPR) is owned by 68.69% institutional shareholders, 174.25% Jasper Therapeutics insiders, and 0.00% retail investors. Roche Holding Ltd is the largest individual Jasper Therapeutics shareholder, owning 9.17M shares representing 32.78% of the company. Roche Holding Ltd's Jasper Therapeutics shares are currently valued at $11.65M.

If you're new to stock investing, here's how to buy Jasper Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.